about
Systemic delivery to central nervous system by engineered PLGA nanoparticlesPromising approaches to circumvent the blood-brain barrier: progress, pitfalls and clinical prospects in brain cancer.Peptides and proteins used to enhance gold nanoparticle delivery to the brain: preclinical approachesBrain delivery of small interfering ribonucleic acid and drugs through intranasal administration with nano-sized polymer micelles.Cone snail venomics: from novel biology to novel therapeutics.Proline-rich antimicrobial peptides: potential therapeutics against antibiotic-resistant bacteria.Early engineering approaches to improve peptide developability and manufacturability.Independent effect of polymeric nanoparticle zeta potential/surface charge, on their cytotoxicity and affinity to cells.Intracellular sorting of differently charged chitosan derivatives and chitosan-based nanoparticles.Intranasal Delivery of Recombinant NT4-NAP/AAV Exerts Potential Antidepressant Effect.The Next Generation Non-competitive Active Polyester Nanosystems for Transferrin Receptor-mediated Peroral Transport Utilizing Gambogic Acid as a LigandIron Oxide Nanoparticle Delivery of Peptides to the Brain: Reversal of Anxiety during Drug Withdrawal.The role of chitosan on oral delivery of peptide-loaded nanoparticle formulation.Molecular engineering solutions for therapeutic peptide delivery.Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles.Biodistribution of the cyclotide MCoTI-II, a cyclic disulfide-rich peptide drug scaffold.Identification and characterization of highly versatile peptide-vectors that bind non-competitively to the low-density lipoprotein receptor for in vivo targeting and delivery of small molecules and protein cargos.Intranasal delivery of a Fas-blocking peptide attenuates Fas-mediated apoptosis in brain ischemiaMembrane Active Peptides and Their Biophysical Characterization
P2860
Q26751294-08EA6BB4-E301-4F98-B60B-E6222BBA91FEQ26778701-0F32FBFE-90CA-4612-9977-BA7152182F80Q26795570-33E0C2B9-FA2B-4BF6-8763-1A6C82FCBAA0Q34961530-65BF1B9C-64DA-43B8-A85A-6808C6D19485Q35432836-32FE1096-CAF3-4EEC-BE9E-56C07D452386Q38241687-42B699BD-0460-4536-B992-301E2D4C65A8Q38262021-EB2DD046-C08C-408E-8904-5E7A853CAF3BQ38870284-7F61C759-B142-4945-B873-EBD21549135EQ38888225-E8611F7E-72AC-4D89-A102-E80B29E0EC13Q40929566-7DCF2267-7F96-497B-A093-7C8218FEF492Q41843707-EA940A50-D050-459F-B400-AE7DBBF10387Q47110352-BCF65039-A4AC-49AE-AD21-29A4693C7ACAQ47449818-34B04915-A0FA-4ECC-AED3-D81275B98D1DQ47680427-AC116FAE-9E1F-40D4-82D6-965AA1870E8FQ48384614-8FAF0159-C4E3-487A-9FAA-6B733987F8D6Q48869308-8DFD171B-C354-4482-8564-6CFAAB5E4E4BQ51746979-3AA55641-DBF9-4CBF-8CAC-653F0B1046DAQ57292417-BED701A3-7107-44B8-822C-09F305200C32Q58717273-746322C9-9ACD-405E-B0F3-9DE02CD378B9
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Strategies to deliver peptide drugs to the brain.
@en
type
label
Strategies to deliver peptide drugs to the brain.
@en
prefLabel
Strategies to deliver peptide drugs to the brain.
@en
P50
P356
P1476
Strategies to deliver peptide drugs to the brain.
@en
P304
P356
10.1021/MP400680D
P407
P577
2014-03-21T00:00:00Z